Of the $1.24 billion in venture investments pumped into Illinois’ life sciences sector last year, about half went to the state’s late-stage companies, Series A rounds accounted for 35% and early-stage companies collected 15% of the funding, according to a report released this morning.
The Illinois Biotechnology Innovation Organization’s inaugural Member Investor Portfolio Report details the venture investment spread among 99 life sciences companies in 2024.
“This report represents a milestone for our community,” John Conrad, president and CEO of the Illinois Biotechnology Innovation Organization, said in a release. “It’s essential that we track investment activity in our region, identify key trends and most importantly, highlight and celebrate the incredible companies that are driving innovation and raising funds despite challenging market conditions.”